Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7

被引：165

作者：

Lindquist, David ^{[1
]}

Romanitan, Mircea ^{[1
]}

Hammarstedt, Lalle ^{[2
]}

Naesman, Anders ^{[1
]}

Dahistrand, Hanna ^{[1
]}

Lindholm, Johan ^{[1
]}

Oneloev, Liselotte ^{[1
]}

Ramqvist, Torbjoern ^{[1
]}

Ye, Weimin ^{[3
]}

Munck-Wikland, Eva ^{[2
]}

Dalianis, Tina ^{[1
]}

机构：

[1] Karolinska Univ Hosp, Canc Ctr Karolinska, Karolinska Inst, Dept Oncol Pathol, S-17176 Stockholm, Sweden

[2] Karolinska Univ Hosp, Karolinska Inst, Dept Oto Rhino Laryngol Head & Neck Surg, S-17176 Stockholm, Sweden

[3] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden

来源：

MOLECULAR ONCOLOGY | 2007年 / 1卷 / 03期

基金：

瑞典研究理事会;

关键词：

Human papillomavirus; Tonsillar carcinoma; Head and neck squamous; cell carcinoma; Viral load; E6; mRNA; E7;

D O I：

10.1016/j.molonc.2007.08.005

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

From 1970 to 2002 in the Stockholm area, we revealed a parallel three-fold increase in the incidence of tonsillar cancer and the proportion of human papillomavirus (HPV) positive tonsillar cancer cases, indicating a possible role of HPV infection in this disease. We have now examined whether HPV and viral load in pre-treatment tonsillar cancer biopsies correlates to disease prognosis, and whether the presence of HPV-16 E6 and E7 mRNA could be ascertained. The presence of HPV-16, but not viral load, in tonsillar cancer was shown to be a favourable prognostic factor for clinical outcome. Moreover, E6 and/or E7 were expressed in almost all assessable HPV-16 positive cases, supporting an oncogenic role of HPV-16 in tonsillar cancer. (C) 2007 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

引用

页码：350 / 355

页数：6

共 32 条

[1] Human papillomaviruses and associated malignancies
Alani, RM
Münger, K
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (01) : 330 - 337
[2] Andl T, 1998, CANCER RES, V58, P5
[3] Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays
Bustin, SA
[J]. JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2000, 25 (02) : 169 - 193
[4] Case-control study of human papillomavirus and oropharyngeal cancer
D'Souza, Gypsyamber
Kreimer, Aimee R.
Viscidi, Raphael
Pawlita, Michael
Fakhry, Carole
Koch, Wayne M.
Westra, William H.
Gillison, Maura L.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (19) : 1944 - 1956
[5] Dahlgren L, 2006, ANTICANCER RES, V26, P829
[6] Human papillomavirus is more common in base of tongue than in mobile tongue cancer and is a favorable prognostic factor in base of tongue cancer patients
Dahlgren, L
Dahlstrand, H
Lindquist, D
Högmo, A
Björnestål, L
Lindholm, J
Lundberg, B
Dalianis, T
Munck-Wikland, E
[J]. INTERNATIONAL JOURNAL OF CANCER, 2004, 112 (06) : 1015 - 1019
[7] High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients
de Boer, Marjon A.
Jordanova, Ekaterina S.
Kenter, Gemma G.
Peters, Alexander A.
Corver, Willem E.
Trimbos, J. Baptist
Fleuren, Gert Jan
[J]. CLINICAL CANCER RESEARCH, 2007, 13 (01) : 132 - 138
[8] Frisch M, 2000, CANCER-AM CANCER SOC, V88, P1464, DOI 10.1002/(SICI)1097-0142(20000315)88:6<1464::AID-CNCR26>3.0.CO
[9] 2-O
[10] Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity
Gillison, ML
[J]. SEMINARS IN ONCOLOGY, 2004, 31 (06) : 744 - 754

← 1 2 3 4 →